| Compounded medication for patients with rare diseases M Dooms, M Carvalho Orphanet journal of rare diseases 13, 1-8, 2018 | 63 | 2018 |
| The role of pharmaceutical compounding in promoting medication adherence M Carvalho, IF Almeida Pharmaceuticals 15 (9), 1091, 2022 | 25 | 2022 |
| Current compounding practices in europe. M Carvalho, C Tuleau, KM Taylor International Journal of Pharmaceutical Compounding 12 (2), 94-99, 2008 | 23 | 2008 |
| Pain management therapy: The benefits of compounded transdermal pain medication A Branvold, M Carvalho J Gen Practice 2 (6), 188, 2014 | 16 | 2014 |
| The dual role of domperidone in gastroparesis and lactation. H Phan, A DeReese, AJ Day, M Carvalho International journal of pharmaceutical compounding 18 (3), 203-207, 2014 | 16 | 2014 |
| Why do we need hospital pharmacy preparation? M Carvalho, K Taylor, C Tuleu European Journal of Hospital Pharmacy 19 (5), 467-468, 2012 | 11 | 2012 |
| Extemporaneously compounded oral medicines in European hospital pharmacies MJ Reis De Carvalho UCL (University College London), 2013 | 8 | 2013 |
| Clinical efficacy of a topical compounded formulation in male androgenetic alopecia: Minoxidil 10%, finasteride 0.1%, biotin 0.2%, and caffeine citrate 0.05% hydroalcoholic … JC Marotta, G Patel, M Carvalho, S Blakeney International Journal of Pharmaceutical Compounding 24 (1), 69-76, 2020 | 7 | 2020 |
| Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications. KE Agbi, M Carvalho, H Phan, C Tuma International Journal of Pharmaceutical Compounding 21 (1), 22-27, 2017 | 7 | 2017 |
| Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox). K Ip, M Carvalho, A Shan, D Banov International Journal of Pharmaceutical Compounding 21 (4), 322-329, 2017 | 4 | 2017 |
| Physicochemical stability of extemporaneously prepared oral suspension of fluconazole 50 mg/mL in SuspendIt™ K Ip, A Shan, M Carvalho, S Baker, D Banov Pharmaceutical Technology in Hospital Pharmacy 3 (2), 101-112, 2018 | 3 | 2018 |
| The role of transdermal compounding in opioid safety. CV Bucher, AJ Day, M Carvalho Journal of Opioid Management 14 (1), 17-22, 2018 | 3 | 2018 |
| Pharmacy student's survey: perceptions and expectations of pharmaceutical compounding. M Carvalho, B Batra International Journal of Pharmaceutical Compounding 19 (1), 18-27, 2015 | 3 | 2015 |
| Compounding practices in a Portuguese community pharmacy. M Reis, M Carvalho, A Rodrigues International Journal of Pharmaceutical Compounding 18 (5), 392-395, 2014 | 3 | 2014 |
| The role of compounding in closing therapeutic gaps-abstracts from FIP 2013: when not to compound and considerations before compounding E Lutz, G Pauletti, M Carvalho, G Davidson, L Ashworth, V Subramaniam, ... Int J Pharm Compd 18 (1), 8-9, 2014 | 3 | 2014 |
| Compounding Practices in Europe: Extemporaneously Compounded Oral Medicines in European Hospital Pharmacies M Carvalho UCL School of Pharmacy, 2013 | 3 | 2013 |
| Compounding around the world MJ Carvalho International Journal of Pharmaceutical Compounding 9 (6), 449, 2005 | 3 | 2005 |
| Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report. N Jones, M Carvalho, A Branvold-Herr International Journal of Pharmaceutical Compounding 21 (3), 205-211, 2017 | 2 | 2017 |
| Evaluation of the in vitro human skin percutaneous absorption of progesterone in Versabase® using the Franz skin finite dose model AS Bassani, D Banov, M Carvalho J Women's Health Care 6 (384), 2167-0420.1000384, 2017 | 2 | 2017 |
| A randomized, double‐blind, controlled study evaluating the effects of two facial serums on skin aging D Banov, M Carvalho, S Schwartz, R Frumento Skin Research and Technology 29 (11), e13522, 2023 | 1 | 2023 |
